Mood Disorders

PLoS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world.

Psychiatric Services VOL 63 No 5. PSS. Columns | May 01, 2012 . Best Practices: The Development and Implementation of No Force First as a Best Practice. Lori Ashcraft, Ph.D.; Michelle Bloss, M.Ed.; William A. Anthony, Ph.D. Dr. Ashcraft

The contributors, who are also on the. DSM-5. Task Force for Anxiety Disorders, include editors Drs. ... The chapters that hooked me were the first three. The first is TSD and Related Disorders, by Matthew Friedman.

Psychiatric Services VOL 63 No 5. PSS. Columns | May 01, 2012 . Best Practices: The Development and Implementation of o Force First ? as a Best Practice. Lori Ashcraft, Ph.D.; Michelle Bloss, M.Ed.; William A. Anthony, Ph.D. Dr.

Abstract. Involuntary outpatient treatment ( IOT) is used as a tool to promote stability among people with psychotic disorders. ... Some evidence suggests that its use is more effective for individuals with schizophrenia than for those with primarily

This study examined the role of comorbid anxiety in treatment outcome for children with mood disorders (N=165; age 8-11) participating in Multi-Family Psychoeducational Psychotherapy (MF-PEP). Assessments occurred at baseline, 6, 12, and 18 months for two randomly assigned groups: immediate treatment and 1-year wait-list. Most children (69%) had comorbid anxiety disorders. Baseline comorbid anxiety, as reported on the Children's Interview for Psychiatric Syndromes (ChIPS), was associated with higher Children's Depression Rating Scale- Revised (CDRS-R) scores but not Young Mania Rating Scale (YMRS) scores. Higher levels of anxiety symptoms were associated with lower Children's Global Assessment Scale (C-GAS) scores. Participation in MF-PEP did not significantly reduce anxiety symptoms (p=0.62). However, presence of comorbid anxiety did not impede reduction in depressive (CDRS-R, p=0.74) or manic (YMRS scores, p=0.94) symptoms following MF-PEP. More baseline

Distinct seasonal variation in hospital admission and various associations with the climatic parameters for mood disorders and schizophrenia have been previously reported in several world regions. There are, however, no North-African studies on this association.|The charts of 1987 patients with mood disorders (mania 1181, depression 806) and 1359 patients with schizophrenia admitted from 2003 to 2007 from an university hospital at Mansoura, Egypt, were reviewed. Seasonality was assessed with Cosinor Analysis. Correlations of the rate of admissions for affective disorders and schizophrenia to climatic variables were performed, including lagged and differenced data.|There was a significant seasonal variation in the monthly admission frequencies both for mania (peak in June) and for depression (peak in December) but no significant seasonal variation was found in admissions with diagnosis of schizophrenia. The number of admissions for mania was positively correlated to indicators of

To examine associations between racial discrimination, mood disorders, and cardiovascular disease (CVD) among Black Americans.|Weighted logistic regression analyses were performed on a nationally representative sample of Black Americans (n = 5022) in the National Survey of American Life (NSAL; 2001-2003). Racial discrimination and CVD were assessed via self-report. Mood disorder was measured with the World Health Organization Composite International Diagnostic Interview.|Model-adjusted risk ratios (RRs) revealed that participants with a history of mood disorder had greater risk of CVD (RR, 1.28; 95% confidence interval (CI), 1.12-1.45). This relationship was found specifically among those younger than 50 years of age (RR, 1.56; 95% CI, 1.27-1.91). There was a significant interaction between racial discrimination and mood disorder in predicting CVD in the total (F= 2.86, 3 df, p = .047) and younger sample (F = 2.98, 3 df, p = .047). Participants with a history of mood disorder who

To examine associations between psychosocial impairment and comorbid disorders in bulimic syndromes.|Participants (N=391; 91% women) completed structured clinical interviews to determine the presence of Axis I disorders (bulimic syndromes, anxiety disorders and mood disorders) and current psychosocial functioning.|Individuals with a current bulimic syndrome and comorbid anxiety disorder had worse psychosocial functioning than either disorder alone. In contrast, there was no additional effect of a current bulimic syndrome in individuals with a current mood disorder on psychosocial impairment.|Findings highlight the importance of addressing comorbid disorders in individuals with bulimic syndromes to improve overall functioning and reduce risk of relapse.

Macrolides are protein synthesis inhibitors exerting an action on the bacterial ribosome. The ribosomes coded for by the human mitochondrial deoxyribonucleic acid (DNA) are similar to those from bacteria in size and structure. In addition, mitochondria are thought to have originated from a symbiotic relationship between an anaerobic proto-eukaryotic cell that engulfed an aerobic bacterium. Morphological changes of mitochondria have been observed in bipolar disorder and schizophrenia. Manic episodes associated with the use of antimicrobial agents have been described since the discovery of isoniazid. The oxidative stress induced in the neuronal mitochondria is thought to underlie this effect. The inhibition of GSK-3 in the intra-mitochondrial Akt signaling pathway is thought to convey mood stabilizing properties. Rapamycin is a macrolide that, besides its antiepileptic effect, restores the Akt function and inhibits the mTOR pathway which may have an antidepressant effect. Accordingly,

Reviews the evidence for and against hundreds of preventive health services, recommending tests, and counseling interventions when evidence exists that it is effective.

NGC is the National Guideline Clearinghouse.

NGC is the National Guideline Clearinghouse.